Chemical Structure : BMS-753426
货号: PC-49142Not For Human Use, Lab Use Only.
BMS-753426 is a potent, selective and orally bioavailable antagonist of CCR2 with binding IC50 of 2.7 nM, 30-fold selectivity over CCR5.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
BMS-753426 is a potent, selective and orally bioavailable antagonist of CCR2 with binding IC50 of 2.7 nM, 30-fold selectivity over CCR5.
BMS-753426 potently inhibits chemotaxis of human peripheral blood mononuclear cells (hPBMCs) induced by 10 nM MCP-1 with IC50 of 0.8 nM.
BMS-753426 (1, 25, and 100 mg/kg, oral) inhibits 28%, 74%, and 78% of monocyte/macrophage influx, respectively, in hCCR2 knock-in (KI) mice, with EC50 of 3.9 nM.
BMS-753426 (25 mg/kg, BID) reduces clinical score, histological evaluation of the spinal cordexperimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis in hCCR2 KI mice.
分子量 | 506.574 | |
分子式 | C25H33F3N6O2 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
1. Michael G Yang, et al. ACS Med Chem Lett. 2021 May 25;12(6):969-975.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright